Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167118 | SCV000217948 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000167118 | SCV000908412 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492674 | SCV002802498 | likely benign | Endometrial carcinoma; Lynch syndrome 5; Mismatch repair cancer syndrome 3 | 2022-04-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995562 | SCV004835011 | likely benign | Lynch syndrome | 2023-03-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005089835 | SCV005786633 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-07-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535133 | SCV004711840 | likely benign | MSH6-related disorder | 2021-11-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |